WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017

May 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-05-02

Reporting Person: Pucci Paolo (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-02	Common Stock	A	1697.00	$0.00	Acquired	2978.184	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Phantom Stock Unit	$		Common Stock (56.2144)	56.2144	Direct

Footnotes

F1: These shares of restricted stock units will vest in full after 8 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F3: Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.